Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives. | Curr Oncol Rep | 2023 | 37801187 | PubTator, text mining | PubMed |
| Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients. | Medicine (Baltimore) | 2023 | 37800836 | PubTator, text mining | PubMed |
| Identification of two immune subtypes and four hub immune-related genes in ovarian cancer through multiple analysis. | Medicine (Baltimore) | 2023 | 37800814 | PubTator, text mining | PubMed |
| Mapping oto-pharyngeal development in a human inner ear organoid model. | Development | 2023 | 37796037 | PubTator, text mining | PubMed |
| Current management and future challenges in salivary glands cancer. | Front Oncol | 2023 | 37795454 | PubTator, text mining | PubMed |
| GPX8 regulates pan-apoptosis in gliomas to promote microglial migration and mediate immunotherapy responses. | Front Immunol | 2023 | 37795080 | PubTator, text mining | PubMed |
| The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition. | Breast Cancer Res | 2023 | 37794509 | PubTator, text mining | PubMed |
| SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models. | J Immunother Cancer | 2023 | 37793853 | PubTator, text mining | PubMed |
| A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37791068 | PubTator, text mining | PubMed |
| Glycine Decarboxylase (GLDC) Plays a Crucial Role in Regulating Energy Metabolism, Invasion, Metastasis and Immune Escape for Prostate Cancer. | Int J Biol Sci | 2023 | 37781511 | PubTator, text mining | PubMed |
| A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs. | Sci Rep | 2023 | 37770477 | PubTator, text mining | PubMed |
| The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer. | Front Immunol | 2023 | 37753093 | PubTator, text mining | PubMed |
| Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly. | World J Gastroenterol | 2023 | 37744296 | PubTator, text mining | PubMed |
| Oral squamous cell carcinomas: state of the field and emerging directions. | Int J Oral Sci | 2023 | 37736748 | PubTator, text mining | PubMed |
| A Novel Scoring Model of Deubiquitination Patterns Predicts Prognosis and Immunotherapeutic Response in Hepatocellular Carcinoma. | Transl Oncol | 2023 | 37734237 | PubTator, text mining | PubMed |
| The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma. | Front Immunol | 2023 | 37731483 | PubTator, text mining | PubMed |
| Development of potent antibody drug conjugates against ICAM1+ cancer cells in preclinical models of cholangiocarcinoma. | NPJ Precis Oncol | 2023 | 37717087 | PubTator, text mining | PubMed |
| FCGR2B as a prognostic and immune microenvironmental marker for gliomas based on transcriptomic analysis. | Medicine (Baltimore) | 2023 | 37713871 | PubTator, text mining | PubMed |
| Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer. | Front Immunol | 2023 | 37711621 | PubTator, text mining | PubMed |
| Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma. | J Otolaryngol Head Neck Surg | 2023 | 37697421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=15